Financhill
Sell
36

OCSL Quote, Financials, Valuation and Earnings

Last price:
$13.79
Seasonality move :
2.45%
Day range:
$13.65 - $13.82
52-week range:
$12.50 - $19.80
Dividend yield:
15.52%
P/E ratio:
105.08x
P/S ratio:
22.13x
P/B ratio:
0.82x
Volume:
756.4K
Avg. volume:
882.6K
1-year change:
-28.18%
Market cap:
$1.2B
Revenue:
$57.6M
EPS (TTM):
$0.13

OCSL Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for Oaktree Specialty Lending shares anticipate an average target of $14.10, ranging from a low estimate of $13.00 to a high estimate of $16.00. This average target implies a growth of 3.22% compared to the current stock price of $13.66.

Consensus Price Target

$14.10

Highest Price Target

$16.00

Lowest Price Target

$13.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 1 1 1

Hold 4 5 5

Sell 0 0 0
Consensus Hold Hold Hold

OCSL Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
QDEL alert for May 10

QuidelOrtho [QDEL] is down 0.22% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock